1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Transcutaneous Electrical Nerve Stimulation Market, by Surgery Procedures
6.1. Introduction
6.2. Direct Nerve Repair
6.3. Nerve Grafting
6.4. Stem Cell Therapy

7. Transcutaneous Electrical Nerve Stimulation Market, by Product
7.1. Introduction
7.2. Desktop
7.3. Portable

8. Transcutaneous Electrical Nerve Stimulation Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospital

9. California Transcutaneous Electrical Nerve Stimulation Market

10. Florida Transcutaneous Electrical Nerve Stimulation Market

11. Illinois Transcutaneous Electrical Nerve Stimulation Market

12. New York Transcutaneous Electrical Nerve Stimulation Market

13. Ohio Transcutaneous Electrical Nerve Stimulation Market

14. Pennsylvania Transcutaneous Electrical Nerve Stimulation Market

15. Texas Transcutaneous Electrical Nerve Stimulation Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. Aleva Neurotherapeutics SA
17.3. BioMedical Life Systems
17.4. Bioness, Inc.
17.5. Boston Scientific Corporation
17.6. Chirag Electronics Private Limited, S.m.r.a
17.7. Cochlear Ltd
17.8. Cogentix Medical, Inc.
17.9. Cyberonics, Inc.
17.10. DJO LLC.
17.11. ElectroCore, Inc.
17.12. EMS Physio Ltd
17.13. Medtronic plc
17.14. NeuroMetrix, Inc.
17.15. NeuroPace Inc
17.16. Nevro Corp
17.17. OMRON Corporation
17.18. R-slimming Medical Systems
17.19. Uroplasty, Inc.
17.20. Zynex Medical

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2027
FIGURE 6. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2027
FIGURE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 20. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2027
FIGURE 22. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: FPNV POSITIONING MATRIX
FIGURE 27. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 28. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY SURGERY PROCEDURES, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DIRECT NERVE REPAIR, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY NERVE GRAFTING, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY STEM CELL THERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY DESKTOP, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY PORTABLE, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SCORES
TABLE 14. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: BUSINESS STRATEGY
TABLE 15. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: PRODUCT SATISFACTION
TABLE 16. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: RANKING
TABLE 17. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 18. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: MERGER & ACQUISITION
TABLE 19. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 20. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 21. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: INVESTMENT & FUNDING
TABLE 22. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 23. UNITED STATES TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET: LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Aleva Neurotherapeutics SA
BioMedical Life Systems
Bioness, Inc.
Boston Scientific Corporation
Chirag Electronics Private Limited, S.m.r.a
Cochlear Ltd
Cogentix Medical, Inc.
Cyberonics, Inc.
DJO LLC.
ElectroCore, Inc.
EMS Physio Ltd
Medtronic plc
NeuroMetrix, Inc.
NeuroPace Inc
Nevro Corp
OMRON Corporation
R-slimming Medical Systems
Uroplasty, Inc.
Zynex Medical